PCN77 COST-EFFECTIVENESS OF OCTREOTIDE LAR IN PATIENTS WITH METASTATIC NEUROENDOCRINE MIDGUT TUMORS FROM THE PRIVATE PAYER PERSPECTIVE IN BRAZIL
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)71972-6
https://www.valueinhealthjournal.com/article/S1098-3015(11)71972-6/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
128
First Page :
A265
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71972-6&doi=10.1016/S1098-3015(11)71972-6